Stock Track | Crinetics Pharmaceuticals Plummets 5.73% Intraday Following Analyst Price Target Reduction

Stock Track

05/08

Crinetics Pharmaceuticals Inc. (CRNX) saw its stock price plummet 5.73% during intraday trading on Friday, marking a significant decline for the healthcare company.

The sharp drop followed news that Citizens lowered its price target on Crinetics to $95 from $97, while maintaining an Outperform rating on the shares. Analyst actions often influence market sentiment, and this price target adjustment appears to have contributed to the selling pressure.

Additional analyst commentary on Crinetics Pharmaceuticals was also published around the market open, with multiple firms weighing in on the healthcare sector and specifically mentioning CRNX, potentially adding to the negative investor reaction during the trading session.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1146256721"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146256721\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146256721?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-08 21:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146256721","market":"sg","top_or_hot":-1,"title":"Stock Track | Crinetics Pharmaceuticals Plummets 5.73% Intraday Following Analyst Price Target Reduction","media":"Stock Track","content":"<p>Crinetics Pharmaceuticals Inc. (CRNX) saw its stock price plummet 5.73% during intraday trading on Friday, marking a significant decline for the healthcare company.</p><p>The sharp drop followed news that Citizens lowered its price target on Crinetics to $95 from $97, while maintaining an Outperform rating on the shares. Analyst actions often influence market sentiment, and this price target adjustment appears to have contributed to the selling pressure.</p><p>Additional analyst commentary on Crinetics Pharmaceuticals was also published around the market open, with multiple firms weighing in on the healthcare sector and specifically mentioning CRNX, potentially adding to the negative investor reaction during the trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Crinetics Pharmaceuticals Plummets 5.73% Intraday Following Analyst Price Target Reduction</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Crinetics Pharmaceuticals Plummets 5.73% Intraday Following Analyst Price Target Reduction\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-05-08 21:47</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Crinetics Pharmaceuticals Inc. (CRNX) saw its stock price plummet 5.73% during intraday trading on Friday, marking a significant decline for the healthcare company.</p><p>The sharp drop followed news that Citizens lowered its price target on Crinetics to $95 from $97, while maintaining an Outperform rating on the shares. Analyst actions often influence market sentiment, and this price target adjustment appears to have contributed to the selling pressure.</p><p>Additional analyst commentary on Crinetics Pharmaceuticals was also published around the market open, with multiple firms weighing in on the healthcare sector and specifically mentioning CRNX, potentially adding to the negative investor reaction during the trading session.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRNX","symbol_name":"Crinetics Pharmaceuticals Inc.","start_time":0,"source_url":"","article_id":"1146256721","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146256721","pubTimestamp":1778248073,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Crinetics Pharmaceuticals Inc. (CRNX) saw its stock price plummet 5.73% during intraday trading on Friday, marking a significant decline for the healthcare company.The sharp drop followed news that...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CRNX":"Crinetics Pharmaceuticals Inc."},"translate_title":"个股追踪|分析师下调目标价后Crinetics制药盘中暴跌5.73%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRNX":1},"content_text":"Crinetics Pharmaceuticals Inc. (CRNX) saw its stock price plummet 5.73% during intraday trading on Friday, marking a significant decline for the healthcare company.The sharp drop followed news that Citizens lowered its price target on Crinetics to $95 from $97, while maintaining an Outperform rating on the shares. Analyst actions often influence market sentiment, and this price target adjustment appears to have contributed to the selling pressure.Additional analyst commentary on Crinetics Pharmaceuticals was also published around the market open, with multiple firms weighing in on the healthcare sector and specifically mentioning CRNX, potentially adding to the negative investor reaction during the trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}